All In MedTech

Device Trial Radar · NCT06236802

ProVIDE II Bridging Study

ProVIDE II Bridging Study for the ProVee System for BPH

Last checked: Nov 19, 2026Latest source record: Jul 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

40

Actual

Start

Mar 6, 2024

Primary completion

Sep 6, 2024

Study completion Jun 1, 2029

Sponsor

Lead sponsor
ProVerum MedicalNot on our public-company list
Sponsor type
Industry
First posted
Feb 1, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.

Conditions

  • BPH With Symptomatic Lower Urinary Tract Symptoms

Interventions

  • ProVee deviceDevice

    ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serious Adverse EventsTime frame: (time frame: procedure to 3 months)
  2. Need for urinary catheterizationTime frame: (time frame: >7 days post procedure to 3-months)
  3. Technical SuccessTime frame: Procedure

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • Florida Urology Partners, LLP

    Tampa, Florida

  • Avant Concierge Urology

    Winter Garden, Florida

  • Comprehensive Urologic Care

    Lake Barrington, Illinois

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.